Long‐Term Safety and Efficacy of JR‐131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study

The objective of this study was to evaluate the safety and efficacy of JR‐131, a biosimilar of darbepoetin alfa, for long‐term treatment of renal anemia patients undergoing hemodialysis. In this multicenter, single‐arm, phase 3 study, 159 patients with renal anemia who had been receiving darbepoetin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Apher Dial
Hlavní autoři: Nishi, Shinichi, Yamada, Masayuki, Tsuruya, Kazuhiko, Masakane, Ikuto, Nakamoto, Hidetomo
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078934/
https://ncbi.nlm.nih.gov/pubmed/31304637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1744-9987.13420
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky